CSL 0.55% $287.92 csl limited

UBS positive on

  1. 5,951 Posts.
    lightbulb Created with Sketch. 281

    CSL Limited (ASX: CSL)

    The first blue chip ASX share to consider is CSL. It is one of the world’s leading biotechnology companies, comprising two businesses – CSL Behring and Seqirus. CSL Behring is the number one player in a global plasma therapies industry worth a massive US$30 billion per year. Whereas Seqirus is the number two player in the US$6 billion global influenza vaccines industry. CSL has been tipped for solid long term growth thanks to increasing demand for its therapies and its lucrative R&D pipeline.

    UBS is positive on CSL. It currently has a buy rating and $330.00 price target on its shares.


 
watchlist Created with Sketch. Add CSL (ASX) to my watchlist
(20min delay)
Last
$287.92
Change
1.570(0.55%)
Mkt cap ! $139.1B
Open High Low Value Volume
$287.99 $289.76 $286.98 $184.0M 638.6K

Buyers (Bids)

No. Vol. Price($)
1 5 $286.40
 

Sellers (Offers)

Price($) Vol. No.
$288.00 260 2
View Market Depth
Last trade - 16.10pm 29/03/2024 (20 minute delay) ?
Last
$288.43
  Change
1.570 ( 0.76 %)
Open High Low Volume
$287.84 $289.73 $286.99 117701
Last updated 15.59pm 29/03/2024 ?
CSL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.